Dissemin is shutting down on January 1st, 2025

Published in

Centers for Disease Control and Prevention, Emerging Infectious Diseases, 6(12), p. 1001-1004, 2006

DOI: 10.3201/eid1206.050860

Links

Tools

Export citation

Search in Google Scholar

Antiretroviral Drug Resistance and Routine Therapy, Cameroon

Journal article published in 2006 by Christian Laurent, Charles Kouanfack, Laurence Vergne, Michèle Tardy, Léopold Zekeng, Nathalie Noumsi, Christelle Butel, Anke Bourgeois, Eitel Mpoudi-Ngolé, Sinata Koulla-Shiro, Martine Peeters, Eric Delaporte ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non-NRTIs, and 2.3% to protease inhibitors.